力恩普制药Lean&Leap

R&D & QUALITY

R&D & Quality

Quality first — safe and effective

QUALITY POLICYQuality Policy

High-standard quality control for human health

Guided by the philosophy of 'quality first, safe and effective'

01

Comply with drug administration laws and regulations, ensuring products meet intended use and registration requirements

02

Establish and advance quality risk management, continually improving the QMS and reducing product quality risks

03

Deliver effective training to constantly raise quality awareness and capability

QUALITY MANAGEMENT SYSTEMQuality Management System

A quality line independent of production

Our QMS is led directly by the General Manager and independent of the production system. The Quality Director serves as the head of quality and the Qualified Person. A comprehensive SOP system is strictly enforced; all operations are recorded and traceable, with prompt customer complaint and product recall procedures. Validation, change, deviation and risk management run through the entire product lifecycle. Over the years, our product quality has remained stable with a 100% market sampling pass rate.

01

Quality Assurance Department

Involved in all quality-related matters, monitoring the entire process of product quality activities.

02

Quality Control Department

Monitoring the whole QC process, comprising the raw-material & finished-product lab, in-process control lab and workshop IPC rooms.

03

International Registration Department

Responsible for overseas product registration, foreign regulatory affairs and technical support for international customers.

04

Site Quality Heads

Authorized by the Quality Director to directly control each site's quality system, with dedicated QA and inspection teams at every site.

LABORATORYTesting & Research

Advanced instruments & a dedicated quality research team

Equipped with HPLC, LC-MS and other advanced instruments for in-process control and finished-product release testing. A dedicated quality research team develops and validates analytical methods and conducts impurity separation, identification and tracking studies.

Advanced instruments & a dedicated quality research team

LC-2030C HPLC

Shimadzu (Japan), for assay and related-substance testing of raw materials, excipients and finished products.

SPEEDGL-10 Polymer Impurity Analyzer

Dedicated detection of penicillin polymer impurities.

LC-MS

For impurity separation, identification and tracking in quality research.

CONSISTENCY EVALUATIONConsistency Evaluation

Generic consistency evaluation

Consistency evaluation dates: Amoxicillin Granules (2022-04-12), Amoxicillin Capsules (2023-08-30), Amoxicillin and Clavulanate Potassium Tablets (2024-03-29), Ampicillin/Sulbactam for Injection (2025-06-03), Amoxicillin/Clavulanate for Injection (2026-01-23) and Piperacillin/Tazobactam for Injection (2026-10-14). See the product directory and company milestones for the corresponding strengths.

R&D CAPABILITYR&D Capability

Over RMB 100 million invested in R&D

0M+
RMB invested in R&D
0
Invention patents
0
Software copyrights
0
Municipal engineering research center
Over RMB 100 million invested in R&D